Finance News World

Chronic Hepatitis Delta Virus (HDV) Infection Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

 Breaking News
  • No posts were found

Chronic Hepatitis Delta Virus (HDV) Infection Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

March 17
14:48 2020
Chronic Hepatitis Delta Virus (HDV) Infection Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

DelveInsight has launched a new report on Chronic Hepatitis Delta Virus (HDV) Infection Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s “Chronic Hepatitis Delta Virus (HDV) Infection Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Chronic Hepatitis Delta Virus (HDV) Infection, historical and forecasted epidemiology as well as the Chronic Hepatitis Delta Virus (HDV) Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan

According to the Hepatitis B Foundation, Hepatitis delta, also known as hepatitis D or HDV is a liver infection caused by the hepatitis delta virus that results in the most severe form of viral hepatitis known to humans. However, only those already infected with hepatitis B can acquire hepatitis delta, as it is dependent on the hepatitis B virus to reproduce. The HDV infection is of two types: super infection and co-infection. Super infections occur when a person with chronic hepatitis B becomes infected with hepatitis delta. These types of infections are more common and have a 70‒90% chance of resulting in a chronic infection of both hepatitis B and delta. Co-infections occur when a person gets infected with hepatitis B and delta at the same time, and have a <5% chance of resulting in chronic infections. HDVC is percutaneously or sexually transmitted through contact with infected blood or blood products. Vertical transmission is possible, but rare.

 

 

Request for :- Chronic Hepatitis Delta Virus (HDV) Infection free sample page

 

Chronic Hepatitis Delta Virus (HDV) Infection Epidemiology

The Chronic Hepatitis Delta Virus (HDV) Infection epidemiology division provide insights about historical and current Chronic Hepatitis Delta Virus (HDV) Infection patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken

 

Some of the Report Key Facts:-

1. According to the study conducted by Kushner et al., titled “Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes,” the HDV seroprevalence of 3.4% among patients with chronic HBV were tested.

 2. The study by Patel et al., titled “Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016,”reported a HDV seroprevalence of 42% among HBsAg (HBV surface antigen) carriers.

 

Report Key Benefits

1. Chronic Hepatitis Delta Virus (HDV) Infection market report covers a descriptive overview and comprehensive insight of the Chronic Hepatitis Delta Virus (HDV) Infection epidemiology Chronic Hepatitis Delta Virus (HDV) Infection market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. Chronic Hepatitis Delta Virus (HDV) Infection market report provides insights on the current and emerging therapies. 

3. Chronic Hepatitis Delta Virus (HDV) Infection market report offers a global historical and forecasted market covering drug outreach in 7 MM.

4. Chronic Hepatitis Delta Virus (HDV) Infection market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Chronic Hepatitis Delta Virus (HDV) Infection market.

 

According to study by Patel et al. (2019), the prevalence of anti-HDV among HBV carriers was found to be more in females than in males”

 

Some of the key companies working on Chronic Hepatitis Delta Virus (HDV) Infection that are given below:-

1. MYR Pharma Co. 

2. Eiger Bio Pharma Co.

 

Name of covered Drugs are given below.

1. Myrcludex B (Bulevirtide)

2. Lonafarnib with Ritonavir

 

Table of Contents

1. Key Insights

2. Executive Summary of Chronic Hepatitis Delta Virus (HDV) Infection

3. Competitive Intelligence Analysis for Chronic Hepatitis Delta Virus (HDV) Infection

4. Chronic Hepatitis Delta Virus (HDV) Infection: Market Overview at a Glance

5. Chronic Hepatitis Delta Virus (HDV) Infection: Disease Background and Overview

6. Patient Journey

7. Chronic Hepatitis Delta Virus (HDV) Infection Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Chronic Hepatitis Delta Virus (HDV) Infection Treatment

11. Marketed Products

12. Emerging Therapies

13. Chronic Hepatitis Delta Virus (HDV) Infection: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Chronic Hepatitis Delta Virus (HDV) Infection

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this Chronic Hepatitis Delta Virus (HDV) Infection market report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Chronic Hepatitis Delta Virus (HDV) Infection market
  • To understand the future market competition in the Chronic Hepatitis Delta Virus (HDV) Infection market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Chronic Hepatitis Delta Virus (HDV) Infection in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Chronic Hepatitis Delta Virus (HDV) Infection market
  • To understand the future market competition in the Chronic Hepatitis Delta Virus (HDV) Infection market

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/